Study of Zemplar iv in Patients With End Stage Chronic Kidney Disease, Undergoing Haemodialysis

NCT01084538 · clinicaltrials.gov ↗

COMPLETED

Status

181

Enrollment

INDUSTRY

Sponsor class

Conditions

Parathyroid Hormone

Interventions

DRUG: Zemplar iv (paricalcitol iv)

Sponsor

Abbott